Breakthrough in ovarian cancer: Selumetinib




Researchers have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors stabilize or shrink after taking a regular dose of the compound selumetinib.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/A...

Viernes, 15 de Febrero 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección